A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes

Nature Medicine

Volumn 20, Issue 8, 2014, Pages 948-953

  Zhang, Bo ^a   Kumar, Rajiv B ^a,b   Dai, Hongjie ^a   Feldman, Brian J ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; GOLD; HUMANS; ISLETS OF LANGERHANS; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY, NEAR-INFRARED; SURFACE PLASMON RESONANCE;

EID: 84905853585     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3619     Document Type: Article

References (31)

1. Smyth, S. & Heron, A. Diabetes and obesity: The twin epidemics. Nat. Med. 12, 75-80 (2006). (Pubitemid 43050080)
2. Karvonen, M. et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23, 1516-1526 (2000).
3. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 355, 873-876 (2000).
4. International Diabetes Federation (IDF). Diabetes in children: Epidemiology. Pediatr. Diabetes 8(S8), 10-18 (2007).
5. Patterson, C.C. et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet 373, 2027-2033 (2009).
6. Maahs, D.M., West, N.A., Lawrence, J.M. & Mayer-Davis, E.J. Epidemiology of type 1 diabetes. Endocrinol. Metab. Clin. North Am. 39, 481-497 (2010).
7. Liese, A.D. et al. The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118, 1510-1518 (2006). (Pubitemid 46393797)
8. Imperatore, G. et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 35, 2515-2520 (2012).
9. Jones, K.L. Role of obesity in complicating and confusing the diagnosis and treatment of diabetes in children. Pediatrics 121, 361-368 (2008). (Pubitemid 351198463)
10. Zeitler, P. Approach to the obese adolescent with new-onset diabetes. J. Clin. Endocrinol. Metab. 95, 5163-5170 (2010).
11. Michels, A.W. & Eisenbarth, G.S. Immune intervention in type 1 diabetes. Semin. Immunol. 23, 214-219 (2011).
12. Greenbaum, C.J., Schatz, D.A., Haller, M.J. & Sanda, S. Through the fog: Recent clinical trials to preserve beta-cell function in type 1 diabetes. Diabetes 61, 1323-1330 (2012).
13. Orban, T. et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled trial. Lancet 378, 412-419 (2011).
14. Greenbaum, C.J., Palmer, J.P., Kuglin, B. & Kolb, H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: Results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J. Clin. Endocrinol. Metab. 74, 1040-1044 (1992).
15. Liu, E. & Eisenbarth, G.S. Accepting clocks that tell time poorly: Fluid-phase versus standard ELISA autoantibody assays. Clin. Immunol. 125, 120-126 (2007). (Pubitemid 47562903)
16. Valdez, S.N. & Poskus, E. Autoimmune diabetes mellitus: The importance of autoantibodies for disease prediction and diagnostic support. Curr. Immunol. Rev. 6, 299-313 (2010).
17. Bottazzo, G.F., Florin-Christensen, A. & Doniach, D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 304, 1279-1283 (1974).
18. Bingley, P.J., Bonifacio, E. & Mueller, P.W. Diabetes Antibody Standardization Program: First assay proficiency evaluation. Diabetes 52, 1128-1136 (2003). (Pubitemid 36523346)
19. Bingley, P.J. et al. Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: Efforts to harmonize procedures among the laboratories. Clin. Trials 7, S56-S64 (2010).
20. Schlosser, M., Mueller, P.W., Torn, C., Bonifacio, E. & Bingley, P.J. Diabetes Antibody Standardization Program: Evaluation of assays for insulin autoantibodies. Diabetologia 53, 2611-2620 (2010).
21. Yu, L. et al. Distinguishing persistent insulin autoantibodies with differential risk: Nonradioactive bivalent proinsulin/insulin autoantibody assay. Diabetes 61, 179-186 (2012).
22. Törn, C. et al. Diabetes Antibody Standardization Program: Evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51, 846-852 (2008).
23. Tabakman, S.M. et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat. Commun. 2, 466 (2011).
24. Zhang, B. et al. Multiplexed cytokine detection on plasmonic gold substrates with enhanced near-infrared fluorescence. Nano Research 6, 113-120 (2013).
25. Achenbach, P. et al. Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. Clin. Immunol. 122, 85-90 (2007). (Pubitemid 46026696)
26. Roberts, M.J., Bentlye, M.D. & Harris, J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54, 459-476 (2002). (Pubitemid 34615543)
27. Oak, S., Phan, T.T., Gilliam, L.K., Hirsch, I.B. & Hampe, C.S. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin. Acta Diabetol. 47, 131-135 (2010).
28. Naserke, H.E., Dozio, N., Ziegler, A.G. & Bonifacio, E. Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41, 681-683 (1998). (Pubitemid 28261403)
29. Ljungberg, U.K. et al. The interaction between different domains of staphylococcal protein A and human polyclonal IgG, IgA, IgM and F(ab′)2: Separation of affinity from specificity. Mol. Immunol. 30, 1279-1285 (1993).
30. Wabl, M., Cascalho, M. & Steinberg, C. Hypermutation in antibody affinity maturation. Curr. Opin. Immunol. 11, 186-189 (1999). (Pubitemid 29154904)
31. Lakowicz, J.R. Radiative decay engineering 5: Metal-enhanced fluorescence and plasmon emission. Anal. Biochem. 337, 171-194 (2005). (Pubitemid 40192533)